These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1694851)

  • 61. Solution phase conformation studies of the prekallikrein binding domain of high molecular weight kininogen.
    Scarsdale JN; Harris RB
    J Protein Chem; 1990 Oct; 9(5):647-59. PubMed ID: 2085389
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Activation of factor XII and prekallikrein with polysaccharide sulfates and sulfatides: comparison with kaolin-mediated activation.
    Shimada T; Sugo T; Kato H; Yoshida K; Iwanaga S
    J Biochem; 1985 Feb; 97(2):429-39. PubMed ID: 2861197
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema.
    Schapira M; Silver LD; Scott CF; Schmaier AH; Prograis LJ; Curd JG; Colman RW
    N Engl J Med; 1983 May; 308(18):1050-3. PubMed ID: 6601240
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Plasma contact activation: a revised hypothesis.
    Schmaier AH
    Biol Res; 1998; 31(3):251-62. PubMed ID: 9830513
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A different cleavage site for high molecular weight kininogen in vivo following intravenous injection of dextran sulfate in the rabbit.
    Wiggins RC
    Circ Res; 1986 Apr; 58(4):595-604. PubMed ID: 2421941
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Accelerating effect of zinc ions on the surface-mediated activation of factor XII and prekallikrein.
    Shimada T; Kato H; Iwanaga S
    J Biochem; 1987 Oct; 102(4):913-21. PubMed ID: 3436959
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex.
    Sugi T; McIntyre JA
    Blood; 1995 Oct; 86(8):3083-9. PubMed ID: 7579402
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Isolation of a cationic fragment of high molecular mass kininogen and effect of this fragment on human plasma kallikrein activity.
    Yarovaya GA; Dotsenko VL; Orekhovich VN
    Clin Chim Acta; 1982 Aug; 123(3):261-7. PubMed ID: 6922013
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mechanism of activation of coagulation factor XI by factor XIIa studied with monoclonal antibodies.
    Akiyama H; Sinha D; Seaman FS; Kirby EP; Walsh PN
    J Clin Invest; 1986 Dec; 78(6):1631-7. PubMed ID: 3491093
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of HMW kininogen in surface-mediated activation of Factor XII.
    Shimada T; Sugo T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():73-85. PubMed ID: 6134440
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The mechanism by which the light chain of cleaved HMW-kininogen augments the activation of prekallikrein, factor XI and Hageman factor.
    Silverberg M; Nicoll JE; Kaplan AP
    Thromb Res; 1980 Oct; 20(2):173-89. PubMed ID: 6908319
    [No Abstract]   [Full Text] [Related]  

  • 72. Isolation and functional properties of the heavy and light chains of human plasma kallikrein.
    van der Graaf F; Tans G; Bouma BN; Griffin JH
    J Biol Chem; 1982 Dec; 257(23):14300-5. PubMed ID: 6815193
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Reduced or unchanged cofactor function of human high molecular weight kininogen induced by human plasma kallikrein.
    Johansen HT; Briseid K
    Adv Exp Med Biol; 1986; 198 Pt A():147-53. PubMed ID: 3492869
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasma.
    Reddigari S; Kaplan AP
    Blood; 1988 May; 71(5):1334-40. PubMed ID: 2451949
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Naturally occurring human antibodies against two distinct functional domains in the heavy chain of FXI/FXIa.
    De La Cadena RA; Baglia FA; Johnson CA; Wenk RE; Amernick R; Walsh PN; Colman RW
    Blood; 1988 Nov; 72(5):1748-54. PubMed ID: 2460161
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High and low molecular weight kininogen and plasma prekallikrein/plasma kallikrein in villous capillaries of human term placenta.
    Hermann A; Buchinger P; Somlev B; Rehbock J
    Placenta; 1996 May; 17(4):223-30. PubMed ID: 8761966
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Whale high-molecular-weight and low-molecular-weight kininogens.
    Semba U; Shibuya Y; Okabe H; Hayashi I; Yamamoto T
    Thromb Res; 2000 Mar; 97(6):481-90. PubMed ID: 10704658
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Structure, kinetics, and function of human and rhesus plasma prekallikreins are similar.
    Veloso D; Smith JI; Denny S; Cosgriff TM
    Thromb Haemost; 1992 Nov; 68(5):526-33. PubMed ID: 1455399
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of chemical modifications on the surface- and protein-binding properties of the light chain of human high molecular weight kininogen.
    Retzios AD; Rosenfeld R; Schiffman S
    J Biol Chem; 1987 Mar; 262(7):3074-81. PubMed ID: 3643926
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Phosphatidylethanolamine induces specific conformational changes in the kininogens recognizable by antiphosphatidylethanolamine antibodies.
    Sugi T; Mclntyre JA
    Thromb Haemost; 1996 Sep; 76(3):354-60. PubMed ID: 8883270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.